Dr. Chun Chao’s research interests include the identification of prognostic biomarkers for cancer disease progression, the identification of predictors for adverse events associated with cancer treatment, and the utilization of HPV vaccine.
Selected Cancer-Related Publications:
Chao C, Silverberg MJ, Martinez-Maza O, Chi M, Abrams DI, Haque R, Zha HD, McGuire M, Xu L, Said JW. Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell lymphoma. Clin Cancer Res. 2012 Jun 18. [Epub ahead of print]
Chao C, Xu L, Abrams DI, Towner WJ, Horberg MA, Leyden WA, Silverberg MJ. HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons. AIDS. 2011 Sep 10;25(14):1771-7.
Chao C, Xu L, Abrams D, Leyden W, Horberg M, Towner W, Klein D, Tang B, Silverberg M. Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy. AIDS. 2010 Jul 17;24(11):1765-70.
Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol. 2010 Feb 1;171(3):357-67. Epub 2010 Jan 4.
Chao C, Slezak JM, Caan BJ, Quinn VP. Alcoholic beverage intake and risk of lung cancer: the California Men's Health Study. Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2692-9.